Restless Legs Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
MEIS1 and LBXCOR1 are developmental factors and raise new pathophysiologic questions for RLS.
|
18541116 |
2008 |
Restless Legs Syndrome
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
MEIS1 has been implicated in limb development, raising the possibility that RLS has components of a developmental disorder.
|
17637780 |
2007 |
Restless Legs Syndrome
|
0.500 |
Biomarker
|
disease |
BEFREE |
MEIS1 has been implicated in limb development, raising the possibility that RLS has components of a developmental disorder.
|
17637780 |
2007 |
Restless Legs Syndrome
|
0.500 |
Biomarker
|
disease |
CTD_human |
MEIS1 has been implicated in limb development, raising the possibility that RLS has components of a developmental disorder.
|
17637780 |
2007 |
Restless Legs Syndrome
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
MEIS1 has been implicated in limb development, raising the possibility that RLS has components of a developmental disorder.
|
17637780 |
2007 |
Sleep Initiation and Maintenance Disorders
|
0.400 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |
Sleep Initiation and Maintenance Disorders
|
0.400 |
Biomarker
|
disease |
CTD_human |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |
Sleeplessness
|
0.330 |
GeneticVariation
|
phenotype |
BEFREE |
While the identified genetic variation in the MEIS1 gene was previously associated with RLS, the two GWAS suggest a novel and independent association with insomnia symptoms.
|
30215811 |
2018 |
Sleeplessness
|
0.330 |
GeneticVariation
|
phenotype |
BEFREE |
We discover loci associated with insomnia symptoms (near MEIS1, TMEM132E, CYCL1 and TGFBI in females and WDR27 in males), excessive daytime sleepiness (near AR-OPHN1) and a composite sleep trait (near PATJ (INADL) and HCRTR2) and replicate a locus associated with sleep duration (at PAX8).
|
27992416 |
2017 |
Sleeplessness
|
0.330 |
Biomarker
|
phenotype |
CTD_human |
Additional analyses favor the hypothesis that MEIS1 exhibits pleiotropy for insomnia and RLS and show that the observed association with insomnia complaints cannot be explained only by the presence of an RLS subgroup within the cases.
|
28604731 |
2017 |
Sleeplessness
|
0.330 |
Biomarker
|
phenotype |
BEFREE |
Additional analyses favor the hypothesis that MEIS1 exhibits pleiotropy for insomnia and RLS and show that the observed association with insomnia complaints cannot be explained only by the presence of an RLS subgroup within the cases.
|
28604731 |
2017 |
Malignant neoplasm of breast
|
0.320 |
Biomarker
|
disease |
CTD_human |
Our results suggest that TMEM25, REPS2 and Meis 1 mRNAs may be useful members of a panel of favourable prognostic and predictive markers for breast cancer and an understanding of their function may provide useful information about this disease.
|
19776672 |
2009 |
Malignant neoplasm of breast
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
Our results suggest that TMEM25, REPS2 and Meis 1 mRNAs may be useful members of a panel of favourable prognostic and predictive markers for breast cancer and an understanding of their function may provide useful information about this disease.
|
19776672 |
2009 |
Breast Carcinoma
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
Our results suggest that TMEM25, REPS2 and Meis 1 mRNAs may be useful members of a panel of favourable prognostic and predictive markers for breast cancer and an understanding of their function may provide useful information about this disease.
|
19776672 |
2009 |
Breast Carcinoma
|
0.320 |
Biomarker
|
disease |
CTD_human |
Our results suggest that TMEM25, REPS2 and Meis 1 mRNAs may be useful members of a panel of favourable prognostic and predictive markers for breast cancer and an understanding of their function may provide useful information about this disease.
|
19776672 |
2009 |
Malignant neoplasm of breast
|
0.320 |
Biomarker
|
disease |
BEFREE |
Utilising quantitative real-time RT-PCR assays, the expression of 20 HOX genes and two known HOX co-factors, PBX1B and MEIS1, were analysed in human melanoma and breast cancer cell lines, comparing results against non-malignant cells.
|
14614318 |
2004 |
Breast Carcinoma
|
0.320 |
Biomarker
|
disease |
BEFREE |
Utilising quantitative real-time RT-PCR assays, the expression of 20 HOX genes and two known HOX co-factors, PBX1B and MEIS1, were analysed in human melanoma and breast cancer cell lines, comparing results against non-malignant cells.
|
14614318 |
2004 |
Chronic Insomnia
|
0.310 |
Biomarker
|
disease |
BEFREE |
In conclusion, our data confirms that MEIS1 is a genetic risk factor for the development of RLS, but it does not support the pleiotropic effect of MEIS1 in CID.
|
30215811 |
2018 |
Chronic Insomnia
|
0.310 |
Biomarker
|
disease |
CTD_human |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |
Primary Insomnia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |
Rebound Insomnia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |
Nonorganic Insomnia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |
Transient Insomnia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |
Early Awakening
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |
Psychophysiological Insomnia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.
|
28604731 |
2017 |